46. PubMed PMID: 7550838. Frequence du reflux CXCR4 Formulation gastrooesophagien chez le nourrisson et le46.

46. PubMed PMID: 7550838. Frequence du reflux CXCR4 Formulation gastrooesophagien chez le nourrisson et le
46. PubMed PMID: 7550838. Frequence du reflux gastrooesophagien chez le nourrisson et le jeune enfant atteints de mucoviscidose. five. Button BM, Roberts S, Kotsimbos TC, Levvey BJ, Williams TJ, Bailey M, et al: Gastroesophageal reflux (symptomatic and silent): a potentially important challenge in individuals with cystic fibrosis just before and following lung transplantation. J Heart Lung Transplant 2005, 24(10):1522529. PubMed PMID: 16210125. six. D’Ovidio F, Singer LG, Hadjiliadis D, Pierre A, Waddell TK, de Perrot M, et al: Prevalence of gastroesophageal reflux in end-stage lung illness candidates for lung transplant. Ann Thorac Surg 2005, 80(4):1254260. PubMed PMID: 16181849. 7. Cystic Fibrosis Foundation Patient Registry: 2010 Annual Information Report. Bethesda M. cff.org/SearchResults/index.cfm cx=014097933530442145544 3Amfnlnb3cjhe q=annual+report+2010. 8. Navarro J, Rainisio M, Harms HK, Hodson ME, Koch C, Mastella G, et al: Variables associated with poor pulmonary function: cross-sectional analysis of information from the ERCF. European Epidemiologic Registry of Cystic Fibrosis. Eur Respir J 2001, 18(two):29805. PubMed PMID: 11529288. 9. Button BM, Heine RG, Catto-Smith AG, Olinsky A, Phelan PD, Ditchfield MR, et al: Chest physiotherapy in infants with cystic fibrosis: to tip or not A five-year study. Pediatr Pulmonol 2003, 35(three):20813. PubMed PMID: 12567389. ten. Sheikh SI, Ryan-Wenger NA, McCoy KS: Outcomes of surgical management of serious GERD in sufferers with cystic fibrosis. Pediatr Pulmonol 2012. PubMed PMID: 22949398. 11. American Lung Association Asthma Clinical Analysis C, Mastronarde JG, Anthonisen NR, Castro M, Holbrook JT, Leone FT, et al: Efficacy ofConclusion Asymptomatic gastroesophageal reflux is present inside the majority of patients with cystic fibrosis. Threat and benefits of acid suppressive agents in cystic fibrosis need additional study.Competing interests Emily DiMango serves around the Advisory Board of Gilead Pharmaceuticals. Patricia Walker serves as a consultant to Gilead Pharmaceuticals. ClaireDiMango et al. BMC Pulmonary Medicine 2014, 14:21 biomedcentral.com/1471-2466/14/Page 7 of12.13.14.15.16.17.18.19.20.21.22.23.24.25.26.27.28.29.30.CCR9 web esomeprazole for remedy of poorly controlled asthma. New Engl J Med 2009, 360(15):1487499. PubMed PMID: 19357404. Pubmed Central PMCID: 2974569. Kiljander TO, Harding SM, Field SK, Stein MR, Nelson HS, Ekelund J, et al: Effects of esomeprazole 40 mg twice daily on asthma: a randomized placebo-controlled trial. Am J Respir Crit Care Med 2006, 173(ten):1091097. PubMed PMID: 16357331. Raghu G, Yang ST, Spada C, Hayes J, Pellegrini CA: Sole therapy of acid gastroesophageal reflux in idiopathic pulmonary fibrosis: a case series. Chest 2006, 129(3):79400. PubMed PMID: 16537884. Lee JS, Ryu JH, Elicker BM, Lydell CP, Jones KD, Wolters PJ, et al: Gastroesophageal reflux therapy is associated with longer survival in sufferers with idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 2011, 184(12):1390394. PubMed PMID: 21700909. Eurich DT, Sadowski CA, Simpson SH, Marrie TJ, Majumdar SR: Recurrent community-acquired pneumonia in sufferers starting acid-suppressing drugs. Am J Med 2010, 123(1):473. PubMed PMID: 20102991. Hermos JA, Young MM, Fonda JR, Gagnon DR, Fiore LD, Lawler EV: Danger of community-acquired pneumonia in veteran patients to whom proton pump inhibitors have been dispensed. Clin Infect Dis 2012, 54(1):332. PubMed PMID: 22100573. de Jager CP, Wever Computer, Gemen EF, van Oijen MG, van Gageldonk-Lafeber AB, Si.